Molecular features of KRAS mutant NSCLC: Weaving a future score for immune-checkpoint inhibitors (ICI)

被引：0
|
作者：
Dorta Suarez, M. [1 ]
Jimenez Munarriz, B. [1 ]
Del Barrio, A. [1 ]
Garcia Ledo, G. [1 ]
Blanco Blanco, R. [1 ]
Conde Gallego, E. [1 ]
Hernandez Prieto, S. [1 ]
Lopez Rios, F. [1 ]
Cubillo Gracian, A. [1 ]
机构：
[1] HM CIOCC Ctr Integral Oncol Clara Campal, Ctr Oncol, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.2008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12P
引用
收藏
页码：S1349 / S1349
页数：1
相关论文
共 50 条
  • [1] Future directions in immune-checkpoint inhibitors in NSCLC
    Hayashi, Hidetoshi
    CANCER SCIENCE, 2018, 109 : 1225 - 1225
  • [2] Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC)
    Mazieres, J.
    Tomasini, P.
    Lusque, A.
    Boucekine, M.
    Gautschi, O.
    Cortot, A. B.
    Couraud, S.
    Thai, A.
    Ng, T.
    Greillier, L.
    Veillon, R.
    Neal, J. W.
    Popat, S.
    Gounant, V.
    Mhanna, L.
    Drilon, A.
    Baron, J. Milia
    Barlesi, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S826 - S827
  • [3] Incorporating Immune-Checkpoint Inhibitors into Systemic Therapy of NSCLC
    Champiat, Stephane
    Ileana, Ecaterina
    Giaccone, Giuseppe
    Besse, Benjamin
    Mountzios, Giannis
    Eggermont, Alexander
    Soria, Jean-Charles
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) : 144 - 153
  • [4] Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
    Zhang, Chao
    Chen, Hua-Fei
    Yan, Shi
    Wu, Lin
    Yan, Li-Xu
    Yan, Xiao-Long
    Yue, Dong-Sheng
    Xu, Chun-Wei
    Zheng, Min
    Li, Ji-Sheng
    Liu, Si-Yang
    Yang, Ling-Ling
    Jiang, Ben-Yuan
    Ou, Qiu-Xiang
    Qiu, Zhen-Bin
    Shao, Yang
    Wu, Yi-Long
    Zhong, Wen-Zhao
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [5] Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
    Chao Zhang
    Hua-Fei Chen
    Shi Yan
    Lin Wu
    Li-Xu Yan
    Xiao-Long Yan
    Dong-Sheng Yue
    Chun-Wei Xu
    Min Zheng
    Ji-Sheng Li
    Si-Yang Liu
    Ling-Ling Yang
    Ben-Yuan Jiang
    Qiu-Xiang Ou
    Zhen-Bin Qiu
    Yang Shao
    Yi-Long Wu
    Wen-Zhao Zhong
    npj Precision Oncology, 6
  • [6] Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
    Mhanna, Laurent
    Milia, Julie
    Lusque, Amellie
    Couraud, Sebastien
    Mascaux, Celine
    Veillon, Remi
    Frueh, Martin
    Moro-Sibilot, Denis
    Lattuca-Truc, Mickael
    Tomasini, Pascale
    Barlesi, Fabrice
    Drilon, Alexander E.
    Gautschi, Oliver
    Mazieres, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [7] Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).
    Mazieres, Julien
    Drilon, Alexander E.
    Mhanna, Laurent
    Milia, Julie
    Lusque, Amellie
    Cortot, Alexis B.
    Mezquita, Laura
    Thai, Alesha
    Couraud, Sebastien
    Veillon, Remi
    Mascaux, Celine
    Schouten, Robert
    Neal, Joel W.
    Ng, Terry L.
    Frueh, Martin
    Peled, Nir
    Gounant, Valerie
    Popat, Sanjay
    Zhu, Viola Weijia
    Gautschi, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC
    Signorelli, D.
    Fortunato, O.
    Pontis, F.
    Capizzuto, V.
    Ferri, R.
    Brambilla, M.
    Ferrara, R.
    Proto, C.
    Lo Russo, G.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Viscardi, G.
    Lobefaro, R.
    Nichetti, F.
    Ganzinelli, M.
    Zilembo, N.
    Colombo, M.
    Sozzi, G.
    Garassino, M. C.
    Jachetti, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S405 - S405
  • [9] Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
    Passiglia, Francesco
    Reale, Maria Lucia
    Cetoretta, Valeria
    Novello, Silvia
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 9 - 26
  • [10] Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
    Jeanson, Arnaud
    Tomasini, Pascale
    Souquet-Bressand, Maxime
    Brandone, Nicolas
    Boucekine, Mohamed
    Grangeon, Mathieu
    Chaleat, Solene
    Khobta, Natalyia
    Milia, Julie
    Mhanna, Laurent
    Greillier, Laurent
    Biemar, Julie
    Nanni, Isabelle
    Ouafik, L'houcine
    Garcia, Stephane
    Mazieres, Julien
    Barlesi, Fabrice
    Mascaux, Celine
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : 1095 - 1101
12345